🇺🇸 FDA
Patent

US 8557298

Medicaments for chemotherapeutic treatment of disease

granted A61KA61K31/352A61K9/0019

Quick answer

US patent 8557298 (Medicaments for chemotherapeutic treatment of disease) held by Provectus Pharmatech, Inc. expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/352, A61K9/0019, A61P, A61P35/00